GSMA
25.2.2020 13:02:04 CET | Business Wire | Press release
The GSMA today announced winners of the 2020 Global Mobile (GLOMO) Awards. The GLOMOs showcase those companies and individuals that are driving innovation in the rapidly evolving mobile industry.
“Our congratulations to all of the winners and nominees of the GSMA’s GLOMO Awards 2020,” said John Hoffman, CEO, GSMA Ltd. “The GLOMOs are a testament to the incredible innovation and ingenuity shaping our industry and it is truly an outstanding achievement to have been selected by our esteemed judging panels. We thank all of our entrants, judges, sponsors and partners for supporting the 2020 GLOMOs.”
The winners of the 2020 GLOMO Awards are:
Best Mobile Network Infrastructure
Vodafone, Parallel Wireless and Telecom Infra Project for Global OpenRAN Deployments
Best Mobile Technology Breakthrough (Companies > $10million Annual Global Revenue)
Ericsson for Ericsson Spectrum Sharing (ESS)
Best Mobile Technology Breakthrough (Companies < $10million Annual Global Revenue)
KaiOS for KaiOS, Enable Tomorrow
Best Network Software Breakthrough (Companies > $10million Annual Global Revenue)
Parallel Wireless for OpenRAN Controller and Network Software
Best Network Software Breakthrough (Companies < $10million Annual Global Revenue)
Cohere Technologies for Improved 4G and 5G FDD/TDD Networks
Best Mobile Authentication & Security Solution
Nuance Communications Inc. for Nuance Gatekeeper
5G Leadership Award
Huawei for Gear up with Huawei’s E2E 5G Products
5G Industry Partnership Award
China Unicom, BMW & Huawei for 5G Digital Factory Enable Automobile Manufacturing Digital Transformation
Outstanding Mobile Technology Award
Ericsson for Ericsson Spectrum Sharing (ESS)
Best Mobile Operator Service for Consumers
Vimplecom for Beeline & Liza Alert
Best Mobile service for the Connected Life
CalAmp for Here Comes The Bus
Most Innovative Mobile App
Turkcell for BiP Translate
Best Mobile Innovation for Work
China Eastern Airlines, China Unicom & Huawei for 5G Smart Travel in Airport
Best Mobile Innovation for Health and Biotech
Flare for World-Class Emergency Response Technologies
Best Mobile Innovation for Automotive
SK Telecom for Smart Fleet: Data Analytics Platform for Intelligent Mobility
Best Mobile Innovation for Payment and FinTech
Juvo for Financial Identity as a Service (FiDaaS)
Best Mobile Innovation for Smart Cities
China Mobile Group Zhejiang and Huawei for NB-IoT Smart City Fire Control
Best Mobile Innovation for Media and Entertainment
LG Uplus for U+VR 5G
Best Mobile Innovation for Building Trust in the Digital Age
Samsung Electronics for Knox Security Platform
Tech of the Future Award
Huawei for Atlas 900 AI Cluster - The Pinnacle of AI Compute for Future Inclusion
Best Smartphone
OnePlus for OnePlus 7T Pro
Disruptive Device Innovation Award
Qualcomm for Qualcomm Snapdragon X55 5G modem
Best Connected Consumer Device
Vasco Electronics for Vasco Mini2
Best Mobile Innovation for Emerging Markets
Safaricom for DigiFarm
Best Mobile Innovation supporting Emergency or Humanitarian Situations
MapSwipe for Missing Maps
Best Mobile Innovation for Accessibility & Inclusion
SK Telecom for Driving Assistance Solution for Hearing-Impaired Taxi Driver
Best Mobile Innovation for Climate Action
Huawei for Huawei PowerStar™ Solution, 3-Level AI-Based Energy Saving solution
Best Mobile Initiative for Enhancing Children’s Lives
Accenture for SAATHI – Autism Therapy at your Fingertips
Outstanding Mobile Contribution to the UN SDGs
KT for Global Epidemic Prevention Platform
Government Leadership Award
The Government of the Kingdom of Saudi Arabia
Outstanding Contribution to the Mobile Industry
Safaricom
Women4Technology – Industry Leadership Award
Elena Sinel, Founder for Teens In AI
Diversity in Tech Award
Teens In AI for Teens In AI
25 Years of Connecting People Award
Dr Mike Short - A constant champion of the role of mobile technology for the enhancement of society
YoMo STEAM Activity for Children Award
SK Telecom for Happy Coding School for Adolescents with Special Needs
For further information on GLOMO Awards winners please visit https://www.globalmobileawards.com/
- ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators and nearly 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200225005494/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom